New Securities Lawsuits Target CoreWeave and Bath & Body Works
Law firms have announced a securities class-action lawsuit against CoreWeave, Inc. for allegedly misleading investors. Separately, investors in Bath & Body Works were reminded of a March 16 deadline to lead a similar lawsuit against that company.
- The lawsuit against CoreWeave covers investors who purchased securities between March 28, 2025, and December 15, 2025. The lead plaintiff motion deadline is March 13, 2026. - Allegations against CoreWeave include overstating its capacity to meet customer demand and understating the risks associated with its reliance on a single third-party data center supplier. - CoreWeave's stock price fell over 6% after the termination of its merger agreement with Core Scientific was announced on October 30, 2025. It dropped again by more than 16% after the company lowered its 2025 revenue guidance on November 10, 2025, citing delays from a third-party developer. - The Bath & Body Works lawsuit pertains to securities purchased between June 4, 2024, and November 19, 2025. - The complaint against Bath & Body Works alleges the company made misleading statements about its growth strategy, which involved pursuing "adjacencies, collaborations and promotions" that were not successfully expanding its customer base. - On August 28, 2025, Bath & Body Works' stock dropped 6.9% after announcing a 55.8% year-over-year decline in earnings per diluted share for the second quarter of 2025 and cutting its full-year guidance. - The company's stock fell an additional 24.8% on November 20, 2025, after it reported a third-quarter revenue decline, slashed its full-year net sales guidance, and announced it would exit some of the "adjacencies" to refocus on its core products.
